Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Stockholm CREAtinine Measurements (SCREAM) Project

NCT06239129 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT06239129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06239129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Stockholm CREAtinine Measurements (SCREAM) Project
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Completed
Start date
January 1, 2006
Completion date
December 31, 2022
Enrollment
3,200,000 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cardiovascular diseases, chronic kidney diseases, diabetes mellitus, hypertension